These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36739901)
1. Comment on "Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study". Long V; Choi E J Am Acad Dermatol; 2023 Apr; 88(4):e173-e174. PubMed ID: 36739901 [No Abstract] [Full Text] [Related]
2. Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study. Kresch M; Weingarten M; Guenin S; Wei N; Elbogen E; Correa da Rosa J; Lebwohl M J Am Acad Dermatol; 2023 May; 88(5):1182-1183. PubMed ID: 36538947 [No Abstract] [Full Text] [Related]
3. Are Systemic Corticosteroids Causing Psoriasis Flare-Ups? Questionnaire for Danish Dermatologists, Gastroenterologists and Rheumatologists. Schwarz CW; Loft N; Andersen V; Juul L; Zachariae C; Skov L Dermatology; 2021; 237(4):588-594. PubMed ID: 33049749 [TBL] [Abstract][Full Text] [Related]
4. Response to comment on the article entitled "Risk of rebound psoriasis flare from systemic corticosteroid use in patients with psoriasis: A retrospective cohort study". Kresch-Vatch M; Lebwohl M J Am Acad Dermatol; 2023 Nov; 89(5):e215. PubMed ID: 36780949 [No Abstract] [Full Text] [Related]
5. Efalizumab-associated papular psoriasis: an adverse reaction to efalizumab in three cases. Antonucci A; Bardazzi F; Balestri R; Patrizi A J Dermatolog Treat; 2009; 20(1):61-2. PubMed ID: 18618361 [TBL] [Abstract][Full Text] [Related]
6. Systemic steroids in the treatment of psoriasis: what is fact, what is fiction? Mrowietz U; Domm S J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):1022-5. PubMed ID: 22830601 [TBL] [Abstract][Full Text] [Related]
7. Flare of pustular psoriasis after initiating ustekinumab therapy. Wenk KS; Claros JM; Ehrlich A J Dermatolog Treat; 2012 Jun; 23(3):212-4. PubMed ID: 21254881 [TBL] [Abstract][Full Text] [Related]
8. Infliximab-induced acne: a new case and review of published reports. Steels E; Peretz A; Vereecken P J Dermatolog Treat; 2009; 20(1):59-60. PubMed ID: 18608731 [No Abstract] [Full Text] [Related]
9. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid. Lebwohl M J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829 [TBL] [Abstract][Full Text] [Related]
15. Immune thrombocytopenia associated with efalizumab therapy for psoriasis. Warkentin TE; Kwon P Ann Intern Med; 2005 Nov; 143(10):761-3. PubMed ID: 16287807 [No Abstract] [Full Text] [Related]
16. [Diffused suberitrodermic psoriasis induced by infliximab]. Bruzzese V Reumatismo; 2007; 59(4):328-31. PubMed ID: 18157290 [TBL] [Abstract][Full Text] [Related]
17. [Ustekinumab in a patient with Crohn's disease and anti-TNF-α-induced psoriasis]. Sansó Sureda A; Rocamora Durán V; Sapiña Camaró A; Royo Escosa V; Bosque López MJ Gastroenterol Hepatol; 2011 Oct; 34(8):546-50. PubMed ID: 21665330 [TBL] [Abstract][Full Text] [Related]
18. Psoriasis flares and rebound phenomenon following exposure and withdrawal of systemic steroids: A systematic review and meta-analysis. Long V; Yew YW; Chandran NS; Choi EC J Am Acad Dermatol; 2022 Sep; 87(3):660-661. PubMed ID: 35033606 [No Abstract] [Full Text] [Related]
19. Unexpected onset of psoriasis during infliximab treatment: comment on the article by Beuthien et al. Grinblat B; Scheinberg M Arthritis Rheum; 2005 Apr; 52(4):1333-4; author reply 1334. PubMed ID: 15818679 [No Abstract] [Full Text] [Related]